ENSYSCE BIOSCIENCES INC (ENSC)
US2936024056 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 0.00 | 1.10M | |||
| Cash Equivalents | 1.12M | 3.10M | 12.30M | N/A | N/A | |||
| Receivables | 97.56K | 300.00K | 400.00K | 0.00 | 100.00K | |||
| Other Current Assets | 1.07M | 1.80M | 2.90M | 200.00K | 0.00 | |||
| Total Current Assets | 2.29M | 5.30M | 15.70M | 200.00K | 1.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| Investments And Advances | N/A | N/A | N/A | 12.60M | N/A | |||
| Other Non-Current Assets | 419.22K | 600.00K | 800.00K | N/A | 195.30M | |||
| Total Non-Current Assets | 419.22K | 600.00K | 700.00K | 12.70M | 195.30M | |||
| TOTAL ASSETS | 2.71M | 5.90M | 16.40M | 12.90M | 196.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 854.70K | 4.30M | 12.70M | N/A | N/A | |||
| Accrued Expenses | 542.26K | 2.30M | 3.40M | N/A | 0.00 | |||
| Accounts Payable | 1.94M | 2.90M | 300.00K | 300.00K | 2.80M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 3.33M | 9.50M | 16.50M | 300.00K | 2.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 100.00K | 4.40M | 800.00K | 600.00K | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | 26.39K | 300.00K | 3.70M | 13.00M | 7.00M | |||
| Total Non-Current Liabilities | -302.02K | 100.00K | 7.80M | 13.80M | 7.50M | |||
| TOTAL LIABILITIES | 3.03M | 9.60M | 24.30M | 14.10M | 10.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -121.56M | -110.90M | -85.80M | -1.20M | 2.50M | |||
| Additional Paid In Capital | 121.23M | 107.20M | 78.00M | N/A | 2.50M | |||
| Minority Interest | -315.21K | -260.00K | -240.00K | N/A | N/A | |||
| Common Shares | 320.00 | 0.00 | 0.00 | 0.00 | 181.20M | |||
| Shares Outstanding | 3.15M | 500.00K | 100.00K | 0.00 | 23.90M | |||
| Tangible Book Value per Share | -0.10 | -7.40 | -79.00 | -46.55 | 7.79 | |||
| Total Shareholders' Equity | -322.86K | -3.70M | -7.90M | -1.20M | 186.20M | |||
| TOTAL LIABILITIES AND EQUITY | 2.71M | 5.90M | 16.40M | 12.90M | 196.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -0.03 | -0.56 | -0.67 | 0.00 | |||
| Current Ratio | 0.69 | 0.56 | 0.95 | 0.67 | 0.43 | |||
| Return On Assets (ROA) | -392.38% | -425.25% | -182.26% | 33.41% | 0.19% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | 0.20% | |||
All data in USD